SEC Form 4 research
| Issuer | Apogee Therapeutics, Inc. |
|---|---|
| Tickers | APGE |
| Reporting owners | 15 |
| Officers and directors | 11 |
| Last public filing | 2026-08-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-05 | Dambkowski Carl | S | 5,500 | $134.17 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.